We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$668M
AUM Growth
+$57.5M
Cap. Flow
+$8.92M
Cap. Flow %
1.34%
Top 10 Hldgs %
38.9%
Holding
134
New
8
Increased
54
Reduced
47
Closed
5

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$6.22M
2
APH icon
Amphenol
APH
+$1.8M
3
TMO icon
Thermo Fisher Scientific
TMO
+$1.02M
4
DHR icon
Danaher
DHR
+$907K
5
XOM icon
ExxonMobil
XOM
+$891K

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$4.47M
2
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$1.87M
3
USB icon
US Bancorp
USB
+$1.57M
4
AAPL icon
Apple
AAPL
+$1.47M
5
MMM icon
3M
MMM
+$787K

Sector Composition

Rank Sector Weight
1 Healthcare 27.14%
2 Technology 24.29%
3 Industrials 13.41%
4 Financials 7.3%
5 Consumer Staples 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$54.2M 8.12%
279,408
-8,424
-3% -$1.47M
MSFT icon
2
Microsoft
MSFT
$3.81T
$35.1M 5.26%
103,093
-643
-0.6% -$202K
SYK icon
3
Stryker
SYK
$127B
$26.9M 4.02%
88,054
+1,226
+1% +$354K
VCSH icon
4
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$26.7M 4%
353,281
-24,668
-7% -$1.87M
JPM icon
5
JPMorgan Chase
JPM
$951B
$25.3M 3.78%
173,724
+2,443
+1% +$336K
WSO icon
6
Watsco Inc
WSO
$12.8B
$20.2M 3.02%
52,869
-35
-0.1% -$11.9K
ECL icon
7
Ecolab
ECL
$80.4B
$18.8M 2.82%
100,730
+2,017
+2% +$347K
JNJ icon
8
Johnson & Johnson
JNJ
$646B
$18.8M 2.81%
113,333
+3,531
+3% +$570K
ALC icon
9
Alcon
ALC
$34.8B
$17.4M 2.6%
211,394
+2,984
+1% +$228K
TMO icon
10
Thermo Fisher Scientific
TMO
$230B
$16.5M 2.47%
31,553
+1,895
+6% +$1.02M
RTX icon
11
RTX Corp
RTX
$285B
$16.1M 2.41%
164,188
+6,690
+4% +$655K
VMC icon
12
Vulcan Materials
VMC
$35.6B
$15.4M 2.3%
68,104
+1,981
+3% +$380K
STE icon
13
Steris
STE
$22.8B
$14.3M 2.15%
63,703
+420
+0.7% +$84K
PAYX icon
14
Paychex
PAYX
$45.2B
$13.8M 2.07%
123,728
+1,707
+1% +$187K
MRK icon
15
Merck
MRK
$366B
$13.2M 1.98%
114,454
-660
-0.6% -$74.9K
CAT icon
16
Caterpillar
CAT
$368B
$13M 1.95%
52,805
+788
+2% +$176K
CPRT icon
17
Copart
CPRT
$30.5B
$11.9M 1.78%
259,916
-12,110
-4% -$502K
ABBV icon
18
AbbVie
ABBV
$451B
$11.8M 1.77%
87,829
+811
+0.9% +$119K
HOLX
19
DELISTED
Hologic
HOLX
$10.8M 1.62%
133,897
+6,315
+5% +$516K
PLTR icon
20
Palantir
PLTR
$448B
$10.4M 1.56%
678,971
+63,885
+10% +$726K
PEP icon
21
PepsiCo
PEP
$193B
$10.1M 1.51%
54,336
+306
+0.6% +$57.1K
WWD icon
22
Woodward
WWD
$20.2B
$10.1M 1.51%
84,613
-395
-0.5% -$41.9K
DHR icon
23
Danaher
DHR
$152B
$9.82M 1.47%
46,159
+4,283
+10% +$907K
CVX icon
24
Chevron
CVX
$396B
$9.22M 1.38%
58,580
+4,681
+9% +$750K
CHD icon
25
Church & Dwight Co
CHD
$24B
$8.88M 1.33%
88,639
+1,135
+1% +$107K

Similar funds

LaFleur & Godfrey's Q2 2023 Portfolio in Review

As of Q2 2023, LaFleur & Godfrey held 134 positions worth $668M, up 9.4% from $610M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

LaFleur & Godfrey's Q2 2023 filing shows 8 new, 54 increased, 47 reduced and 5 closed positions. Its largest new stake was Charles Schwab: 118,695 shares worth $6.73M. The largest sale was Goldman Sachs, an estimated $4.47M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • LaFleur & Godfrey's largest Q2 2023 buy was Charles Schwab: 118,695 shares worth $6.73M.
  • LaFleur & Godfrey added most to Thermo Fisher Scientific in Q2 2023, an estimated $1.02M increase.
  • LaFleur & Godfrey's biggest Q2 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.87M.
  • LaFleur & Godfrey fully exited Goldman Sachs in Q2 2023, selling an estimated $4.47M.
  • LaFleur & Godfrey's ten largest holdings make up 39% of its $668M portfolio in Q2 2023.
  • LaFleur & Godfrey opened 8 new positions and closed 5 in Q2 2023.
  • LaFleur & Godfrey's portfolio value rose 9.4% quarter-over-quarter to $668M.

Based on LaFleur & Godfrey's 13F filing for Q2 2023, filed 20 Jul 2023.